Stemline Therapeutics Becomes Oversold (STML)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Wednesday, shares of Stemline Therapeutics Inc ( STML) entered into oversold territory, hitting an RSI reading of 29.97, after changing hands as low as $8.05 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 57.1. A bullish investor could look at STML's 29.97 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of STML shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Stemline Therapeutics Inc 1 Year Performance Chart

Looking at the chart above, STML's low point in its 52 week range is $5.50 per share, with $14.60 as the 52 week high point — that compares with a last trade of $8.10.

More from Stocks

Palo Alto Networks Is Set for an Upside Breakout and Rally Back to the Highs

Palo Alto Networks Is Set for an Upside Breakout and Rally Back to the Highs

Dow Soars on Signs of Progress in U.S.-China Trade Discussions

Dow Soars on Signs of Progress in U.S.-China Trade Discussions

Under Armour Is Tripped Up by Concerns Over North American Sales

Under Armour Is Tripped Up by Concerns Over North American Sales

FedEx and UPS Set to Deliver Gains During Santa Claus Rally

FedEx and UPS Set to Deliver Gains During Santa Claus Rally

Chart of the Day: Can Dave & Buster's Benefit From the Fall of the Mall?

Chart of the Day: Can Dave & Buster's Benefit From the Fall of the Mall?